S

Standigm

45 employees

Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Artificial Intelligence
Drug Discovery
Deep Learning
Health Care
NLP
Bot Modeling
AI Drug Discovery
Target Identification
Active Data Parsing
Biological Interpretation
Drug Repurposing
Lead Generation
Workflow AI
Machine Learning

Date founded

2015

Funding rounds raised

Total raised

$36M

from 10 investors over 10 rounds

S

Standigm raised $36M on March 5, 2021

Investors: Korea Development Bank Europe, LB Investment, Kakao Ventures, Daishin Securities and InterVest

S

Standigm raised $12M on March 1, 2019

Investors: DSC Investment, LB Investment and Kakao Ventures

S

Standigm raised $3M on August 1, 2016

Investors: LB Investment and Kakao Ventures

FAQ